Sarepta Therapeutics (SRPT) Non-cash Items (2010 - 2025)
Sarepta Therapeutics' quarterly Non-cash Items came in at $5.8 million in Q4 2025, down 7.71% year-on-year from $6.3 million in Q4 2024, and down 7.71% quarter-over-quarter from $6.3 million in Q4 2024.
Sarepta Therapeutics has reported Non-cash Items for 16 years, with the latest figure at $5.8 million in Q4 2025.
- For the quarter ending Q4 2025, Non-cash Items fell 7.71% year-over-year to $5.8 million; the trailing twelve-month figure through Dec 2025 stood at $5.8 million (down 7.71% YoY), and the FY2025 full-year result was $5.8 million, down 7.71% from the prior year.
- Non-cash Items for Q4 2025 stood at $5.8 million, down from $6.3 million in the prior quarter.
- The five-year high for Non-cash Items was $557.9 million in Q4 2022, with the low at $5.8 million in Q4 2025.
- Average Non-cash Items over 5 years is $164.9 million, with a median of $6.3 million recorded in 2024.
- Year-over-year, Non-cash Items soared 12198.98% in 2021 and plunged 98.93% in 2023.
- Tracing SRPT's Non-cash Items over 5 years: stood at $248.5 million in 2021, then surged by 124.54% to $557.9 million in 2022, then sank by 98.93% to $6.0 million in 2023, then rose by 5.31% to $6.3 million in 2024, then fell by 7.71% to $5.8 million in 2025.
- The last three Non-cash Items figures came in at $5.8 million (Q4 2025), $6.3 million (Q4 2024), and $6.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.78 Mn |
| Dec 31, 2025 | 5.78 Mn |
| Dec 31, 2024 | 6.27 Mn |
| Dec 31, 2024 | 6.27 Mn |
| Dec 31, 2023 | 5.95 Mn |
| Dec 31, 2023 | 5.95 Mn |
| Dec 31, 2022 | 557.93 Mn |
| Dec 31, 2022 | 557.93 Mn |
| Dec 31, 2021 | 248.48 Mn |
| Dec 31, 2021 | 248.48 Mn |
| Dec 31, 2020 | 2.02 Mn |
| Dec 31, 2020 | 2.02 Mn |
| Dec 31, 2019 | 2.37 Mn |
| Dec 31, 2019 | 2.37 Mn |
| Dec 31, 2018 | 2.30 Mn |
| Dec 31, 2018 | 2.30 Mn |
| Dec 31, 2017 | 3.29 Mn |
| Dec 31, 2017 | 3.29 Mn |
| Dec 31, 2016 | 2.94 Mn |
| Dec 31, 2016 | 2.94 Mn |
| Jun 30, 2016 | 3.40 Mn |
| Jun 30, 2016 | 3.40 Mn |
| Mar 31, 2016 | 3.40 Mn |
| Mar 31, 2016 | 3.40 Mn |
| Dec 31, 2015 | 2.62 Mn |
| Dec 31, 2015 | 2.62 Mn |
| Dec 31, 2014 | 2.02 Mn |
| Dec 31, 2014 | 2.02 Mn |
| Sep 30, 2014 | 1.86 Mn |
| Sep 30, 2014 | 1.86 Mn |
| Jun 30, 2014 | 1.64 Mn |
| Jun 30, 2014 | 1.64 Mn |
| Mar 31, 2014 | 1.18 Mn |
| Mar 31, 2014 | 1.18 Mn |
| Dec 31, 2013 | 1.05 Mn |
| Dec 31, 2013 | 1.05 Mn |
| Sep 30, 2013 | 891,157.00 |
| Sep 30, 2013 | 891,157.00 |
| Jun 30, 2013 | 64.74 Mn |
| Jun 30, 2013 | 64.74 Mn |
| Mar 31, 2013 | 656,805.00 |
| Mar 31, 2013 | 656,805.00 |
| Dec 31, 2012 | 615,394.00 |
| Dec 31, 2012 | 615,394.00 |
| Dec 31, 2011 | 742,211.00 |
| Dec 31, 2011 | 742,211.00 |
| Dec 31, 2010 | 653,253.00 |
| Dec 31, 2010 | 653,253.00 |